MELI vs SNDX · P/E 43, rev $19.01B vs rev $137.7M
MercadoLibre Inc. (MELI) versus Syndax Pharmaceuticals Inc (SNDX) — a side-by-side from cached financials, not a winner call.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.
MELI currently screens at market cap $82.73B and trailing P/E 43.1. SNDX currently screens at market cap $774.4M.
Not investment advice. Open the MELI and SNDX stock pages for the full models.
Not investment advice.